Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2026-01-05 @ 1:52 AM
Study NCT ID:
NCT00628303
Status:
WITHDRAWN
Last Update Posted:
2012-08-01
First Post:
2008-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 3 Trial of the Effect of Motavizumab Prophylaxis on Reduction of Serious Early Childhood Wheezing in Infants
Sponsor:
MedImmune LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-10
Start Date Type:
None
Primary Completion Date:
2011-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2011-12
Completion Date Type:
ESTIMATED
First Submit Date:
2008-02-20
First Submit QC Date:
None
Study First Post Date:
2008-03-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-07-30
Last Update Post Date:
2012-08-01
Last Update Post Date Type:
ESTIMATED